Cargando…
Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
BACKGROUND: Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an ex...
Autores principales: | Hemstra, Line Ea, Schlosser, Anders, Lindholt, Jes Sanddal, Sorensen, Grith L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994031/ https://www.ncbi.nlm.nih.gov/pubmed/29884190 http://dx.doi.org/10.1186/s12967-018-1523-6 |
Ejemplares similares
-
Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2021) -
Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2013) -
Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020) -
Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2015) -
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
por: Johansson, Sofie Lock, et al.
Publicado: (2019)